High-yield recombinant influenza B virus strain and its application
An influenza B virus, influenza virus technology, applied in the direction of antiviral agents, viruses/phages, medical preparations containing active ingredients, etc., can solve the problems of low yield, increase the difficulty of transfection, and limit the use of cell lines, etc. Achieving the effect of high application value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0075] Example 1 Obtaining of the entire genome of influenza B virus
[0076] Strains: B / Jingke / 96 / 01 is from the National Influenza Center, B / Sichuan / 379 / 99 and B / HongKong / 330 / 01 are from the US CDC.
[0077] RT-PCR: The screened strain B / Jingke / 96 / 01 was serially diluted, inoculated into MDCK cells, and the virus was harvested 72 hours later. Viral RNA was extracted using RNeasy KIT (Qiagen), dissolved in 30ul of water and diluted.
[0078] The RT-PCR reaction system was denatured at 94°C for 3 minutes and extended at 55°C for 1 hour. The reverse transcriptase was provided by Invitrogen, and then the PCR system was 94°C 45Sec 50°C 45Sec 72°C 420Sec, and the PFU enzyme was purchased from (Promega).
[0079] Amplify the entire genome of B / Jingke / 96 / 01, use BM-NS-1BM-NS-2 primers to amplify the HA and NA fragments of popular strains, and connect the PCR products to the PGEM-T vector (Promega Company) superior.
[0080] The result obtained through the method of the present inv...
Embodiment 2
[0086] Construction of embodiment 2 PIVVII plasmid
[0087] One: Construction of PIVV II plasmid:
[0088] see Figure 10 and Figure 11 Plasmid map and experimental rationale shown.
[0089] 1: Features of the PIVV II plasmid: The inventors constructed the PIVV II plasmid. The characteristic of the plasmid is that it has both polymerase I and polymerase II promoter and terminator sequences, and the direction of the promoter of polymerase I and polymerase II is opposite. The viral genome is inserted between the promoter of polymerase 1 and the BSMB1 site of the terminator sequence, and the genome of the virus is transcribed under the action of the polymerase 1 promoter, and the viral genome is transcribed under the action of the polymerase II promoter. mRNA, which translates the viral protein,
[0090] 2: Construction method of PIVV II plasmid: amplify the promoter and terminator sequence of PHH21 plasmid (gifted by Neumann G), and use primers:
[0091] Upstream: 5'ATCCC...
Embodiment 3
[0094] Example 3 The fragments of the viral genome are connected to the PIVV II vector respectively
[0095] The PIVV II plasmid vector obtained in Example 2 was digested with BSMB1 and linearized, and then the linearized PIVV II fragment was recovered with a Qiagen recovery kit. Similarly, the target fragment ligated to the PGEM-T vector was digested with BSMB1, and then the target fragment was recovered. Connect the fragments described in sequences 1-8 to the PIVV II vector respectively, the system is 3ul target fragment, 1ul vector, 1ulT 4 DNA ligase (Promega) 15ulddH 2 O, thereby obtaining the connection product PIVV II-BX.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com